Six Indian women have made it to Asia's most powerful women list released by Forbes.
Two career-best centuries by Rakesh Solanki (186) and Yusuf Pathan (183) helped hosts Vadodara take a 145-run first innings lead against Bengal as they piled a mammoth 515 runs on the penultimate day of their four-day Ranji Trophy Elite Group 'B' match at the Motibaug Palace ground in Vadodara on Saturday.
A quiz on women who have made it big in the corporate world.
Nobex, after running out of money last year, had filed for bankruptcy.
Blaming it on the "ineffective" bureaucracy and "very confused" ruling coalition in Karnataka, Kiran Mazumdar-Shaw, managing director of Biocon Ltd on Friday said infrastructural woes were impeding the growth of Bangalore.
Addressing a press briefing, health ministry Joint Secretary Lav Agarwal said currently there are no approved therapies for COVID-19 and there is not enough evidence to claim that plasma therapy can be used for treatment of the disease.
In a bid to enter the Rajya Sabha from West Bengal, Communist Party of India-Marxist politburo members Sitaram Yechuri and Brinda Karat on Monday filed their nominations for the upcoming election to the Upper House.
East Bengal named Bikash Panji as the interim coach for the upcoming Durand Cup
Leading biotech firm, Biocon Ltd, on Tuesday said it would invest $10 million (about Rs 45 crore) in the next 12 months to expand its facilities.
Biocon Ltd ill seek Drug Controller General of India's approval for its novel monoclonal antibody indicated towards the treatment of head and neck cancer, Biomab EGFR.
The company expects insulin, its other branded formulations and research services to drive growth.
Three Indian women -- ICICI Bank deputy managing director Chanda Kochhar, HSBC India CEO Naina Lal Kidwai and Biocon head Kiran Mazumdar-Shaw -- have been named among the world's 50 most powerful businesswomen by the Fortune magazine.
Jeff Bezos of Amazon tops the list for the second consecutive year with networth of $147 billion.
The Enforcement Directorate probing the multi-crore Saradha scam money trail today interrogated Rajya Sabha Trinamool Congress MP Ahmed Hassan Imran for the second time.
Replying to Mumbai's first innings of 115, Hyderabad were 253 for 5 at stumps on day 2 of the Ranji Trophy match.
Dubai-based don Aftab Ansari, the main accused, was convicted for murder, conspiracy and waging war against the country.
'India Inc has been afraid to criticise the government of the day for many years now, and it is perhaps unfair to blame the current one alone,' says Shyamal Majumdar.
Indian biotech firm Biocon is developing potential 'blockbuster' drugs for treatment of cancer and diabetes, which could hit the market in two to four years.
Earlier, Jaslok Hospital had issued an advisory to its doctors to avoid prescribing drugs manufactured by Ranbaxy.
The AAP government locked Principal Secretary (Services) Anindo Majumdar out of his office on Monday.
New Zealand Prime Minister Helen Clarke on Monday said there were immense opportunities to enhance bilateral trade with India.
Test discard Wasim Jaffer scored an unbeaten 206 as Mumbai amassed 329 for 2 by close of day 1 in the Elite Group 'A' Ranji Trophy match against Delhi.
US, China and Japan have no quotas for women and have had the lowest increase in female directors.
Biotech major Biocon will file an application with the US Federal Drug Administration to begin clinical trials for oral insulin, which, it says, would be the world's first insulin that could be consumed orally.
"We are growing fast. We are planning to double the manpower to 4,000 from 2,000 at present. Within a very short period we increased the number of employees by 500 to reach 2000," Biocon Chairman and Managing Director Kiran Mazumdar Shaw said.
Profit up due to strong performance of biopharma segment.
Fine bowling by Ashraf Makda and Hitesh Majumdar helped Gujarat restrict Madhya Pradesh to 242 for 7.
India's largest biotech firm Biocon on Wednesday launched its "recombinant human insulin (r-DNA), Insugen
In an interview with Business Standard, Mazumdar-Shaw spells out her plans for the institution over coming years.
On course to become India's first biotech company to be listed on a stock exchange, Bangalore-based Biocon Ltd on Thursday kicked off a roadshow for its initial public offering that opens on March 11.
Biocon on Thursday reported a 12 per cent decline in consolidated net profit to Rs 174 crore (Rs 1.74 billion) for the year ended March 31, 2006 from Rs 198 crore (Rs 1.98 billion) in FY05.\n
Bureaucratic delays are stifling growth in the sector. India should be far more aggressive in launching 'look alike' biological molecules in a fast track manner.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances